Tag: Acurate neo
PROGRESS PVL: One-year safety and performance outcomes for the ACURATE neo Aortic Valve System
NOTE: This video is ONLY available to watch in selected countries and geographies
Won-K...
Boston Scientific reveals CE mark for Acurate neo 2 in Q1 financial results report
Boston Scientific, according to a press release announcing the company’s Q1 2020 financial resul...
Selecting the right valve for the patient is key for a successful TAVI program
NOTE: This video is ONLY available to watch in selected countries and geographies
TCT 2019: Acurate neo does not meet non-inferiority compared to Sapien 3
The first randomised trial to compare the safety and efficacy of the Acurate neo transcatheter h...
Novel repositionable TAVI valve has acceptable early clinical outcomes
A new study indicates that the Meridian transcatheter aortic valve implantation (TAVI) valve (HL...
Lotus Edge becomes third TAVI device on US market
Boston Scientific has received US FDA approval for its Lotus Edge transcatheter aortic valve imp...
ADVERTORIAL: Unique design and features of the ACURATE neo (TM) enable safe and efficient procedures
This content is only for readers outside of the US as it discusses a device that is not FDA appr...
PCR LV 2018: Favourable outcomes for next-generation Acurate neo2 TAVI system
A new study evaluating the safety and performance of the Acurate neo2 (Boston Scientific) transc...
Boston Scientific successfully opposes Edwards Lifesciences Corporation’s European patent EP 2,399,550 (550)
According to a press release, Boston Scientific has, along with several other opponents, success...
UK Court of Appeal dismisses Edwards Lifesciences’ appeal against Sapien 3 infringement ruling
Acurate neo
Boston Scientific has announced the UK Court of Appeal dismissed Edwards Lifesc...
